News

LC-OCT non-invasively assessed non-structural changes from botulinum toxin and irreversible tissue changes from microwave thermolysis in hyperhidrosis.

BPO may prevent post-operative infections with limited risk of microbial resistance in surgery of sebaceous areas, according to a new study.

Martin Zaiac, MD, gave insight on potential risks associated with manipulation of nails, hygiene, and when it is necessary to see a specialist.

This month's Legal Eagle column explores if a dermatologist can be sued for charging a fee for providing medical records in a lawsuit.

The recent news of counterfeit Botox resulted in patients with blurred vision, difficulty swallowing, shortness of breath, and additional symptoms.

The authorization of DermaSensor marks a milestone in AI-enabled devices, highlighting opportunities and challenges in their integration into clinical practice.

Perceived stress, however, did not exhibit any correlations with psycho- and skin physiological parameters.

Individuals in Uyo, Nigeria, with albinism are at great risk of developing photodermatoses due to a lack of photoprotection and awareness of photoprotective behaviors.

Laura Bush reflects on her term as SDPA president, discussing achievements, challenges, and the future of dermatology PAs in health care.

From a financial perspective, the change from resident to attending dermatologist may be profound.

Patricia Richey, MD, delves into efficacy of the 1927 and 1550 nanometer lasers to prevent skin cancers.

Eli Lilly recently hosted a panel discussion with Olympic athlete Suni Lee to discuss the importance of finding a dermatologist who understands the burden of AD.

Rob Casquejo, PA-C, spoke with Dermatology Times on new and upcoming medications, addressing unmet needs, and social media misinformation.

In this month's Cosmetic Conundrums column, Zoe Diana Draelos, MD, examines the most popular active ingredients in redness-reducing formulations.

In one study, less than 5% of images from a HAM10000 database came from patients with darker skin types.

Sara Osborne, a fourth-year medical student and the lead author on the study, spoke with Dermatology Times on key findings and explain the need for further investigation.

Cutaneous and advanced stage melanomas present significant challenges during pregnancy, according to the posters.

A recent review found that disparities and barriers, such as income, age, and location, can impede patient access to necessary care.

Omar Noor, MD, and a patient with psoriasis share their unique perspectives on moderate to severe plaque psoriasis treatment with tildrakizumab.

Dermatologic emergency units are increasingly overwhelmed by rising patient volumes and reduced resources, but store-and-forward teledermatology offers an effective alternative.

Ethan Sims, MD, spoke with Dermatology Times on having positive conversations, cutting down on waste, and how to get involved in change.

Keep up with the latest headlines in dermatology from the past week, including high wait times to access dermatologic care in Quebec, the rise of digital dermatology, and more.

In case you missed it, this week had news about the 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference, the FDA-approved expanded use of tirbanibulin for actinic keratosis, FDA and EMA support of continuing MoonLake's phase 3 trial of sonelokimab for PsA, and more.

The program’s creator, Hubert Greenway, MD, has personally trained each of the fellowship’s 68 physicians in Mohs surgery.

Weekend treatment with cyclosporine may be beneficial for patients with moderate to severe psoriasis, according to a new study.

The organizations called for skin health to be considered a global public health priority in a recent side meeting at the World Health Assembly.

Researchers compared the examination's content outline with data on skin diseases in a recent study.

Although acne is common for most people to experience in their lifetime, it is important to individualize treatment and provide appropriate care when working with a diverse patient base.

Two new forms of Trichophyton mentagrophytes type VII and Trichophyton indotineae are emerging, according to a new report.

Terry Arnold, PA-C, shares a wide range of opportunities to take clinical experience to a different setting and tips to transition.